Recently, the launch ceremony of the 2026 National Drug Safety Awareness Week was held in Beijing. The event focused on cutting-edge practices in pharmaceutical and medical device safety supervision, and exchanged views on topics such as pharmaceutical innovation achievements, regulatory system reform, and industry development opportunities. Supervisory officials shared many major developments with industry experts, such as full drug chain traceability, new medical device production standards, cell and gene therapy, brain-computer interface standard system construction, and high-end formulation innovation, to empower industrial innovation through scientific supervision and protect the safety of people's medicinal devices.

Recently, the launch ceremony of the 2026 National Drug Safety Awareness Week was held in Beijing. The event focused on cutting-edge practices in pharmaceutical and medical device safety supervision, and exchanged views on topics such as pharmaceutical innovation achievements, regulatory system reform, and industry development opportunities. Supervisory officials shared many major developments with industry experts, such as full drug chain traceability, new medical device production standards, cell and gene therapy, brain-computer interface standard system construction, and high-end formulation innovation, to empower industrial innovation through scientific supervision and protect the safety of people's medicinal devices.